Michele Ciccarelli to Pandemics
                                
                                
                                    This is a "connection" page, showing publications Michele Ciccarelli has written about Pandemics.
                                
                                
                                
                                    
                                        
                                                
    
        
        
        
            Connection Strength
            
                
            
            0.021
         
        
        
     
 
    
        
        - 
            Workers' Compensation, Return to Work, Behavioural Health and COVID-19 in Australia. J Law Med. 2021 Mar; 28(2):546-566.
            
            
                Score: 0.008
             
- 
            Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality. Eur Heart J Cardiovasc Pharmacother. 2020 11 01; 6(6):412-414.
            
            
                Score: 0.002
             
- 
            Effectiveness of Streptococcus Pneumoniae Urinary Antigen Testing in Decreasing Mortality of COVID-19 Co-Infected Patients: A Clinical Investigation. Medicina (Kaunas). 2020 Oct 29; 56(11).
            
            
                Score: 0.002
             
- 
            Timing of national lockdown and mortality in COVID-19: The Italian experience. Int J Infect Dis. 2020 Nov; 100:193-195.
            
            
                Score: 0.002
             
- 
            Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19. Heart. 2020 10; 106(19):1512-1518.
            
            
                Score: 0.002
             
- 
            Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients. J Autoimmun. 2020 11; 114:102511.
            
            
                Score: 0.002
             
- 
            High mortality in COVID-19 patients with mild respiratory disease. Eur J Clin Invest. 2020 Sep; 50(9):e13314.
            
            
                Score: 0.002
             
- 
            Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020 10 15; 383(16):1522-1534.
            
            
                Score: 0.002